Immix Biopharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:IMMX Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
10 Dec 25	BuyUS$4,976	Ilya Rachman	Individual	746	US$6.67
10 Dec 25	BuyUS$5,067	Gabriel Morris	Individual	770	US$6.58
17 Sep 25	BuyUS$5,050	Ilya Rachman	Individual	2,500	US$2.02
16 Sep 25	BuyUS$5,122	Gabriel Morris	Individual	2,600	US$1.97
18 Jun 25	BuyUS$4,999	Ilya Rachman	Individual	2,178	US$2.30
18 Jun 25	BuyUS$5,071	Gabriel Morris	Individual	2,225	US$2.28

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of IMMX?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	3,915,913	7.39%
Hedge Funds	5,811,399	11%
Individual Insiders	6,799,369	12.8%
General Public	15,183,558	28.6%
Institutions	21,301,853	40.2%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 91.2%.

Top Shareholders

Top 25 shareholders own 65.06% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
7.4%	Janus Henderson Group plc	3,921,568	US$38.6m	0%	0.01%
7.39%	Veritas Liberabit Vos, LLC	3,915,913	US$38.6m	0%	no data
6.11%	Yekaterina Chudnovsky	3,241,076	US$31.9m	0%	no data
5.66%	Saturn V Capital Management LP	2,999,169	US$29.5m	0%	4.8%
5.3%	Millennium Management LLC	2,812,230	US$27.7m	69.4%	0.02%
4.81%	Eventide Asset Management, LLC	2,549,019	US$25.1m	0%	0.38%
3.73%	Marshall Wace LLP	1,978,743	US$19.5m	3,500%	0.02%
2.83%	Adage Capital Management, L.P.	1,500,000	US$14.8m	0%	0.02%
2.15%	Ilya Rachman	1,141,683	US$11.2m	0.07%	no data
2.07%	The Vanguard Group, Inc.	1,095,814	US$10.8m	50.1%	no data
1.93%	Mesa Verde Venture Partners	1,025,221	US$10.1m	0%	no data
1.89%	Bleichroeder LP	1,000,000	US$9.8m	17.7%	1.82%
1.89%	Logos Global Management, L.P.	1,000,000	US$9.8m	0%	0.54%
1.86%	CHI Advisors LLC	986,240	US$9.7m	0%	4.65%
1.85%	Franklin Resources, Inc.	980,392	US$9.7m	0%	no data
1.78%	Jason Hsu	943,000	US$9.3m	0%	no data
0.94%	Patricia Gallup	496,940	US$4.9m	0%	no data
0.85%	Columbia Management Investment Advisers, LLC	452,147	US$4.5m	0%	no data
0.85%	Alwaysraise LLC	450,985	US$4.4m	52.9%	no data
0.8%	Nancy Chang	421,940	US$4.2m	0%	no data
0.74%	Susquehanna International Group, LLP	393,887	US$3.9m	334%	no data
0.64%	Perceptive Advisors LLC	338,941	US$3.3m	0%	0.06%
0.55%	Burkehill Global Management, LP	294,118	US$2.9m	0%	0.2%
0.55%	Gabriel Morris	291,429	US$2.9m	0.26%	no data
0.49%	Renaissance Technologies LLC	258,600	US$2.5m	1,100%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/04/27 12:26
End of Day Share Price	2026/04/24 00:00
Earnings	2025/12/31
Annual Earnings	2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Immix Biopharma, Inc. is covered by 5 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Reni Benjamin	Citizens JMP Securities, LLC
Jyoti Prakash	Edison Investment Research
Robert Burns	H.C. Wainwright & Co.